MA06.08 A Safety Study of Avelumab plus SBRT in Malignant Mesothelioma

Authors :: A. Rimner
E. Yorke
D. Gelblum
A. Shepherd
D. Guttmann
A. Iqbal
R. Daly
M. Offin
J. Fiore
A. Namakydoust
H. Li
M. Mccune
E. Gelb
N. Taunk
D. Von Reibnitz
P. Adusumilli
M.S.K. Center
M. Zauderer
Source :: Journal of Thoracic Oncology. 16:S154
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
Avelumab
medicine.medical_specialty
business.industry
Internal medicine
Medicine
Mesothelioma
business
medicine.disease
medicine.drug

Full Text Access

Tools